A direct inhibition effect of miR-200a on KEAP1 was elucidated in human MDA-MB-231 and Hs578T breast and esophageal squamous cell carcinoma cells under methylseleninic acid (MSA) treatment. The gene discussed is KEAP1; the disease is esophageal squamous cell carcinoma.